Advisers to the Food and Drug Administration said using ecstasy to boost therapy for people with post-traumatic stress disorder was not effective.
Related Posts
White House turns to health care in Biden’s latest move against ‘corporate greed’
The announcement is expected to be touted this week, alongside efforts to increase competition in food, housing and other kitchen table issues.
Alzheimer’s program renewal on the way, lawmakers say
“It could easily be part of this package,” he said. “I’ll certainly push that it should be part of it.” Kaine said he was among […]
HHS braces for a reorganization
The effort is part of the Trump administration’s plan to shrink the federal government.